Early research (Phase 1)Study completedNCT01797198
What this trial is testing
Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy Subjects
Who this might be right for
Drug-Drug Interaction (DDI)Healthy Subjects
Astellas Pharma Europe B.V. 48